Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 76 citing articles:

E3 Ligase Ligands for PROTACs: How They Were Found and How to Discover New Ones
Tasuku Ishida, Alessio Ciulli
SLAS DISCOVERY (2020) Vol. 26, Iss. 4, pp. 484-502
Open Access | Times Cited: 250
KEAP1‐NRF2 protein–protein interaction inhibitors: Design, pharmacological properties and therapeutic potential
Enrique Crisman, Pablo Duarte, E. Daudén, et al.
Medicinal Research Reviews (2022) Vol. 43, Iss. 1, pp. 237-287
Open Access | Times Cited: 114
E3 ligase ligand chemistries: from building blocks to protein degraders
Izidor Sosič, Aleša Bricelj, Christian Steinebach
Chemical Society Reviews (2022) Vol. 51, Iss. 9, pp. 3487-3534
Closed Access | Times Cited: 92
Harnessing the E3 Ligase KEAP1 for Targeted Protein Degradation
Jieli Wei, Fanye Meng, Kwang‐Su Park, et al.
Journal of the American Chemical Society (2021) Vol. 143, Iss. 37, pp. 15073-15083
Open Access | Times Cited: 101
Expanding the arsenal of E3 ubiquitin ligases for proximity-induced protein degradation
Aimo Kannt, Ivan Đikić
Cell chemical biology (2021) Vol. 28, Iss. 7, pp. 1014-1031
Open Access | Times Cited: 99
Nrf2 activation through the inhibition of Keap1–Nrf2 protein–protein interaction
Sumi Lee, Longqin Hu
Medicinal Chemistry Research (2020) Vol. 29, Iss. 5, pp. 846-867
Open Access | Times Cited: 95
Targeting NRF2 to treat cancer
Jared Sivinski, Donna D. Zhang, Eli Chapman
Seminars in Cancer Biology (2021) Vol. 76, pp. 61-73
Open Access | Times Cited: 63
Small molecules targeting protein–protein interactions for cancer therapy
Defa Wu, Yang Li, Lang Zheng, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 10, pp. 4060-4088
Open Access | Times Cited: 32
E3 Ligases Meet Their Match: Fragment-Based Approaches to Discover New E3 Ligands and to Unravel E3 Biology
Iacovos N. Michaelides, Gavin W. Collie
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 5, pp. 3173-3194
Open Access | Times Cited: 26
PROTACs: A novel strategy for cancer drug discovery and development
Xin Han, Yi Sun
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 24
Intramolecular Friedel–Crafts Reactions of Sulfamoyl Fluorides, Fluorosulfates, and Sulfuramidimidoyl Fluorides
Taijie Guo, Long Xu, Jiajia Dong
Organic Letters (2025) Vol. 27, Iss. 6, pp. 1356-1361
Closed Access | Times Cited: 1
Recent progress in Keap1-Nrf2 protein-protein interaction inhibitors
Yi Mou, Shuai Wen, Yuxiu Li, et al.
European Journal of Medicinal Chemistry (2020) Vol. 202, pp. 112532-112532
Closed Access | Times Cited: 68
Computational Chemistry on a Budget: Supporting Drug Discovery with Limited Resources
Henriëtte M. G. Willems, Stéphane De Cesco, Fredrik Svensson
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 18, pp. 10158-10169
Open Access | Times Cited: 54
Covalent modification of Keap1 at Cys77 and Cys434 by pubescenoside a suppresses oxidative stress-induced NLRP3 inflammasome activation in myocardial ischemia-reperfusion injury
Yuanyuan Cheng, Liangkai Cheng, Xiang Gao, et al.
Theranostics (2020) Vol. 11, Iss. 2, pp. 861-877
Open Access | Times Cited: 53
Potent Natural Antioxidant Carveol Attenuates MCAO-Stress Induced Oxidative, Neurodegeneration by Regulating the Nrf-2 Pathway
Imran Riaz Malik, Fawad Ali Shah, Tahir Ali, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 51
Emerging Substrate Proteins of Kelch-like ECH Associated Protein 1 (Keap1) and Potential Challenges for the Development of Small-Molecule Inhibitors of the Keap1-Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Protein–Protein Interaction
Yong Zhang, Zeyu Shi, Yujun Zhou, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 15, pp. 7986-8002
Closed Access | Times Cited: 50
Catalytic Synthesis of Cyclic Guanidines via Hydrogen Atom Transfer and Radical-Polar Crossover
Shunya Ohuchi, Hiroki Koyama, Hiroki Shigehisa
ACS Catalysis (2021) Vol. 11, Iss. 2, pp. 900-906
Closed Access | Times Cited: 44
Deconstructing Noncovalent Kelch-like ECH-Associated Protein 1 (Keap1) Inhibitors into Fragments to Reconstruct New Potent Compounds
Jakob S. Pallesen, Dilip Narayanan, Kim T. Tran, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 8, pp. 4623-4661
Open Access | Times Cited: 42
Development of Noncovalent Small-Molecule Keap1-Nrf2 Inhibitors by Fragment-Based Drug Discovery
Dilip Narayanan, Kim T. Tran, Jakob S. Pallesen, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 21, pp. 14481-14526
Closed Access | Times Cited: 29
Structure-based design of a phosphotyrosine-masked covalent ligand targeting the E3 ligase SOCS2
Sarath Ramachandran, Nikolai Makukhin, Kevin Haubrich, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 17
Advances in developing noncovalent small molecules targeting Keap1
Marilia Barreca, Yuting Qin, M Cadot, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 12, pp. 103800-103800
Open Access | Times Cited: 16
Emerging Screening Approaches in the Development of Nrf2–Keap1 Protein–Protein Interaction Inhibitors
Chung‐Hang Leung, Jia-Tong Zhang, Guan‐Jun Yang, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 18, pp. 4445-4445
Open Access | Times Cited: 47
Isoquinoline Kelch-like ECH-Associated Protein 1-Nuclear Factor (Erythroid-Derived 2)-like 2 (KEAP1-NRF2) Inhibitors with High Metabolic Stability
Phillip R. Lazzara, Brian P. David, Aparna Ankireddy, et al.
Journal of Medicinal Chemistry (2019) Vol. 63, Iss. 12, pp. 6547-6560
Open Access | Times Cited: 43
Recent progress in the development of small molecule Nrf2 activators: a patent review (2017-present)
Hai-Shan Zhou, Yan Wang, Qidong You, et al.
Expert Opinion on Therapeutic Patents (2020) Vol. 30, Iss. 3, pp. 209-225
Closed Access | Times Cited: 42
Mining Natural Products for Macrocycles to Drug Difficult Targets
Fabio Begnini, Vasanthanathan Poongavanam, Björn Over, et al.
Journal of Medicinal Chemistry (2020) Vol. 64, Iss. 2, pp. 1054-1072
Open Access | Times Cited: 39
Page 1 - Next Page

Scroll to top